サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300841

創薬アウトソーシングの世界市場規模調査＆予測：ワークフロー別、治療領域別、薬剤タイプ別、サービスタイプ別、エンドユーザー別、地域別分析、2023-2030年

Global Drug Discovery Outsourcing Market Size study & Forecast, by Workflow, by Therapeutics Area, by Drug Type (Small Molecules, Large Molecules ), by Service Type, by End user and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創薬アウトソーシングの世界市場規模調査＆予測：ワークフロー別、治療領域別、薬剤タイプ別、サービスタイプ別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年06月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬アウトソーシング市場は2022年に約35億米ドルと評価され、予測期間2023-2030年には7.5%以上の健全な成長率で成長すると予測されています。

創薬アウトソーシング市場とは、製薬企業やバイオテクノロジー企業が創薬研究開発プロセスのさまざまな段階をCRO（医薬品開発業務受託機関）やその他の専門サービスプロバイダーにアウトソーシングすることを指します。ターゲット同定、ヒットツーリード最適化、前臨床試験、臨床試験、規制当局への申請など、創薬に関連する特定の業務や責任を外部に委ねることになります。世界の創薬アウトソーシング市場の主な促進要因は、心血管疾患の有病率の上昇と高齢者人口の増加です。さらに、主要市場プレーヤーによるイニシアティブの高まりと製剤の進歩が、予測期間にわたって世界の創薬アウトソーシング市場に有利な成長機会を生み出しています。

同地域では、心血管疾患、がん、呼吸器疾患などの慢性疾患の負担が大きいことから、創薬アウトソーシング分野の市場成長が期待されています。例えば、CDC National Center for Health Statisticsによると、2021年時点で米国の18歳以上の成人の4.9%が冠動脈性心疾患を患っています。このような慢性疾患の有病率の増加は、安全で効果的な治療法の開発に対する需要の高まりを生み出し、それによって研究開発受託機関（CRO）との協力の必要性を加速させています。さらに、提携や買収を含む主要企業による戦略的イニシアチブは、同地域における創薬アウトソーシング市場の成長に貢献すると期待されています。こうした取り組みの一例として、2022年1月にShanghai Fosun Pharmaceutical (Group) Co., LtdとInsilico Medicineとの間で締結された提携契約が挙げられます。この提携は、InsilicoのAI主導の創薬・開発能力を活用し、さまざまな世界的標的をターゲットとする医薬品の創出を推進することを目的としています。この提携では、4つの生物学的標的の研究開発に焦点を当てた研究開発提携プロジェクトに1,300万米ドルが投資されました。しかし、創薬アウトソーシングのコストが高いことが、2023-2030年の予測期間を通じて市場の成長を阻害しています。

創薬アウトソーシングの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、確立された製薬企業やバイオテクノロジー企業の存在により、創薬アウトソーシング市場を独占しています。特に米国はアウトソーシング産業が活発で、規制環境も整っているため、市場の成長を牽引しています。高度な医療インフラ、強力な研究開発能力、新規治療薬に対する需要の増加といった要因が、この地域の市場成長に寄与しています。アジア太平洋地域は、創薬アウトソーシング市場において急速な成長を遂げています。中国、インド、日本、韓国などの国々が主要なアウトソーシング拠点として台頭してきており、その主な理由は、人口の多さ、コスト面の優位性、ライフサイエンス分野の専門知識の高まりにあります。医療・インフラへの投資の増加、可処分所得の増加、有利な政府政策がこの地域の市場成長を促進しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 創薬アウトソーシング市場：地域別、2020-2030年
    • 創薬アウトソーシング市場：ワークフロー別、2020-2030年
    • 創薬アウトソーシング市場：治療領域別、2020-2030年
    • 創薬アウトソーシング市場：薬剤タイプ別、2020～2030年
    • 創薬アウトソーシング市場：サービスタイプ別、2020-2030年
    • 創薬アウトソーシング市場：エンドユーザー別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 世界の創薬アウトソーシング市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の創薬アウトソーシング市場力学

  • 創薬アウトソーシング市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 心血管疾患の増加
      • 高齢者人口の増加
    • 市場の課題
      • 創薬アウトソーシングの高コスト
    • 市場機会
      • 製剤の進歩
      • 主要市場プレイヤーによるイニシアティブの高まり

第4章 世界の創薬アウトソーシング市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 創薬アウトソーシングの世界市場：ワークフロー別

  • 市場スナップショット
  • 創薬アウトソーシングの世界市場：ワークフロー別、業績-潜在能力分析
  • 創薬アウトソーシングの世界市場：ワークフロー別推定・予測、2020～2030年
  • 創薬アウトソーシング市場、サブセグメント分析
    • ターゲット同定・スクリーニング
    • ターゲットバリデーション・機能インフォマティクス
    • リード同定・候補の最適化
    • 前臨床開発
    • その他の関連ワークフロー

第6章 創薬アウトソーシングの世界市場：治療領域別

  • 市場スナップショット
  • 創薬アウトソーシングの世界市場：治療領域別、業績-潜在能力分析
  • 創薬アウトソーシングの世界市場：治療領域別推定・予測、2020～2030年
  • 創薬アウトソーシング市場、サブセグメント分析
    • 呼吸器系
    • 疼痛・麻酔
    • 腫瘍
    • 眼科
    • その他

第7章 創薬アウトソーシングの世界市場：薬剤タイプ別

  • 市場スナップショット
  • 創薬アウトソーシングの世界市場：薬剤タイプ別、業績-潜在能力分析
  • 創薬アウトソーシングの世界市場：薬剤タイプ別推定・予測、2020～2030年
  • 創薬アウトソーシング市場、サブセグメント分析
    • 低分子
    • 高分子（バイオ医薬品）

第8章 創薬アウトソーシングの世界市場、サービスタイプ別

  • 市場スナップショット
  • 創薬アウトソーシングの世界市場：サービスタイプ別実績-ポテンシャル分析
  • 創薬アウトソーシングの世界市場：サービスタイプ別推定・予測、2020～2030年
  • 創薬アウトソーシング市場、サブセグメント分析
    • 化学サービス
    • 生物学サービス

第9章 創薬アウトソーシングの世界市場：エンドユーザー別

  • 市場スナップショット
  • 創薬アウトソーシングの世界市場：エンドユーザー別実績-ポテンシャル分析
  • 創薬アウトソーシングの世界市場：エンドユーザー別推定・予測、2020～2030年
  • 創薬アウトソーシング市場、サブセグメント分析
    • 製薬・バイオテクノロジー企業
    • 学術機関
    • その他

第10章 創薬アウトソーシングの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 創薬アウトソーシング市場、地域別市場スナップショット
  • 北米
    • 米国
      • ワークフローの推定・予測、2020-2030年
      • 治療領域の推定・予測、2020～2030年
      • 薬剤タイプ別の推定・予測、2020-2030年
      • サービスタイプの推定・予測、2020-2030年
      • エンドユーザーの推定・予測、2020-2030年
    • カナダ
  • 欧州の創薬アウトソーシング市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の創薬アウトソーシング市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの創薬アウトソーシング市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第11章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Albany Molecular Research Inc
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • EVOTEC
    • Laboratory Corporation of America Holdings
    • GenScript
    • Pharmaceutical Product Development, LLC
    • Charles River
    • WuXi AppTec
    • Merck & Co., Inc.
    • Thermo Fisher Scientific Inc.
    • Dalton Pharma Services

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Drug Discovery Outsourcing Market, report scope
  • TABLE 2. Global Drug Discovery Outsourcing Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Drug Discovery Outsourcing Market estimates & forecasts by Workflow 2020-2030 (USD Billion)
  • TABLE 4. Global Drug Discovery Outsourcing Market estimates & forecasts by Therapeutics Area 2020-2030 (USD Billion)
  • TABLE 5. Global Drug Discovery Outsourcing Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
  • TABLE 6. Global Drug Discovery Outsourcing Market estimates & forecasts by Service Type 2020-2030 (USD Billion)
  • TABLE 7. Global Drug Discovery Outsourcing Market estimates & forecasts by End user 2020-2030 (USD Billion)
  • TABLE 8. Global Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Drug Discovery Outsourcing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Drug Discovery Outsourcing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Drug Discovery Outsourcing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Drug Discovery Outsourcing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Drug Discovery Outsourcing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Drug Discovery Outsourcing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Drug Discovery Outsourcing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Drug Discovery Outsourcing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Drug Discovery Outsourcing Market
  • TABLE 73. List of primary sources, used in the study of global Drug Discovery Outsourcing Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Drug Discovery Outsourcing Market, research methodology
  • FIG 2. Global Drug Discovery Outsourcing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Drug Discovery Outsourcing Market, key trends 2022
  • FIG 5. Global Drug Discovery Outsourcing Market, growth prospects 2023-2030
  • FIG 6. Global Drug Discovery Outsourcing Market, porters 5 force model
  • FIG 7. Global Drug Discovery Outsourcing Market, pest analysis
  • FIG 8. Global Drug Discovery Outsourcing Market, value chain analysis
  • FIG 9. Global Drug Discovery Outsourcing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Drug Discovery Outsourcing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Drug Discovery Outsourcing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Drug Discovery Outsourcing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Drug Discovery Outsourcing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Drug Discovery Outsourcing Market, regional snapshot 2020 & 2030
  • FIG 15. North America Drug Discovery Outsourcing Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Drug Discovery Outsourcing Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Drug Discovery Outsourcing Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Drug Discovery Outsourcing Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Drug Discovery Outsourcing Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Drug Discovery Outsourcing Market is valued approximately USD 3.5 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2023-2030. The Drug Discovery Outsourcing Market refers to the practice of pharmaceutical and biotechnology companies outsourcing various stages of the drug discovery and development process to contract research organizations (CROs) or other specialized service providers. It involves delegating specific tasks and responsibilities related to drug discovery, such as target identification, hit-to-lead optimization, preclinical and clinical trials, and regulatory submissions, to external entities. The major driving factors for the Global Drug Discovery Outsourcing Market is rising prevalence of cardiovascular diseases and growing geriatric population. Moreover, rising initiatives by key market players and advancements in formulation is creating lucrative growth opportunity in the Global Drug Discovery Outsourcing Market over the forecast period.

The high burden of chronic diseases such as cardiovascular diseases, cancer, and respiratory diseases in the region is expected to drive market growth in the drug discovery outsourcing sector. For example, according to the CDC National Center for Health Statistics, as of 2021, 4.9% of adults aged 18 and over in the United States had coronary heart disease. This increasing prevalence of chronic diseases creates a growing demand for the development of safe and effective treatments, thereby accelerating the need for collaborations with Contract Research Organizations (CROs). Furthermore, the strategic initiatives undertaken by key players, including partnerships and acquisitions, are expected to contribute to the growth of the drug discovery outsourcing market in the region. An example of such initiatives is the collaboration agreement between Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Insilico Medicine in January 2022. This partnership aimed to leverage Insilico's AI-driven drug discovery and development capabilities to advance the discovery of drugs targeting various global targets. The collaboration involved an investment of USD 13 million for R&D collaboration projects, focusing on the research and development of four biological targets. However, the high cost of Drug Discovery Outsourcing stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Discovery Outsourcing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominates the drug discovery outsourcing market due to the presence of established pharmaceutical and biotechnology companies. The United States, in particular, has a robust outsourcing industry and a favorable regulatory environment, driving market growth. Factors such as advanced healthcare infrastructure, strong research and development capabilities, and increasing demand for novel therapeutics contribute to market growth in this region. The Asia Pacific region is experiencing rapid growth in the drug discovery outsourcing market. Countries such as China, India, Japan, and South Korea are emerging as major outsourcing hubs, primarily due to their large population, cost advantages, and growing expertise in life sciences. Increasing investments in healthcare infrastructure, rising disposable incomes, and favorable government policies are driving market growth in this region.

Major market players included in this report are:

  • Albany Molecular Research Inc.
  • EVOTEC
  • Laboratory Corporation of America Holdings
  • GenScript
  • Pharmaceutical Product Development, LLC
  • Charles River
  • WuXi AppTec
  • Merck & Co., Inc.
  • Thermo Fisher Scientific Inc.
  • Dalton Pharma Services

Recent Developments in the Market:

  • In November 2022, Sanofi, a leading pharmaceutical company, and Insilico Medicine, a clinical-stage biotechnology company, announced a significant drug development deal worth USD 1200 million. As part of this agreement, Sanofi will utilize Insilico's AI platform, Pharma.AI, to accelerate drug development efforts focused on up to six new targets.

Global Drug Discovery Outsourcing Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Workflow, Therapeutics Area, Drug Type, Service Type, End user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Workflow offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Workflow:

  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Other Associated Workflow

By Therapeutics Area:

  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Others

By Drug Type:

  • Small Molecules
  • Large Molecules (Biopharmaceuticals)

By Service Type:

  • Chemistry Services
  • Biology Services

By End user:

  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Drug Discovery Outsourcing Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Drug Discovery Outsourcing Market, by Workflow, 2020-2030 (USD Billion)
    • 1.2.3. Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2030 (USD Billion)
    • 1.2.4. Drug Discovery Outsourcing Market, by Drug Type, 2020-2030 (USD Billion)
    • 1.2.5. Drug Discovery Outsourcing Market, by Service Type, 2020-2030 (USD Billion)
    • 1.2.6. Drug Discovery Outsourcing Market, by End user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Discovery Outsourcing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Outsourcing Market Dynamics

  • 3.1. Drug Discovery Outsourcing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cardiovascular diseases
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Drug Discovery Outsourcing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation
      • 3.1.3.2. Rising initiatives by key market players

Chapter 4. Global Drug Discovery Outsourcing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Outsourcing Market, by Workflow

  • 5.1. Market Snapshot
  • 5.2. Global Drug Discovery Outsourcing Market by Workflow, Performance - Potential Analysis
  • 5.3. Global Drug Discovery Outsourcing Market Estimates & Forecasts by Workflow 2020-2030 (USD Billion)
  • 5.4. Drug Discovery Outsourcing Market, Sub Segment Analysis
    • 5.4.1. Target Identification & Screening
    • 5.4.2. Target Validation & Functional Informatics
    • 5.4.3. Lead Identification & Candidate Optimization
    • 5.4.4. Preclinical Development
    • 5.4.5. Other Associated Workflow

Chapter 6. Global Drug Discovery Outsourcing Market, by Therapeutics Area

  • 6.1. Market Snapshot
  • 6.2. Global Drug Discovery Outsourcing Market by Therapeutics Area, Performance - Potential Analysis
  • 6.3. Global Drug Discovery Outsourcing Market Estimates & Forecasts by Therapeutics Area 2020-2030 (USD Billion)
  • 6.4. Drug Discovery Outsourcing Market, Sub Segment Analysis
    • 6.4.1. Respiratory system
    • 6.4.2. Pain and Anesthesia
    • 6.4.3. Oncology
    • 6.4.4. Ophthalmology
    • 6.4.5. Others

Chapter 7. Global Drug Discovery Outsourcing Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Drug Discovery Outsourcing Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Drug Discovery Outsourcing Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
  • 7.4. Drug Discovery Outsourcing Market, Sub Segment Analysis
    • 7.4.1. Small Molecules
    • 7.4.2. Large Molecules (Biopharmaceuticals)

Chapter 8. Global Drug Discovery Outsourcing Market, by Service Type

  • 8.1. Market Snapshot
  • 8.2. Global Drug Discovery Outsourcing Market by Service Type, Performance - Potential Analysis
  • 8.3. Global Drug Discovery Outsourcing Market Estimates & Forecasts by Service Type 2020-2030 (USD Billion)
  • 8.4. Drug Discovery Outsourcing Market, Sub Segment Analysis
    • 8.4.1. Chemistry Services
    • 8.4.2. Biology Services

Chapter 9. Global Drug Discovery Outsourcing Market, by End user

  • 9.1. Market Snapshot
  • 9.2. Global Drug Discovery Outsourcing Market by End user, Performance - Potential Analysis
  • 9.3. Global Drug Discovery Outsourcing Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
  • 9.4. Drug Discovery Outsourcing Market, Sub Segment Analysis
    • 9.4.1. Pharmaceutical & Biotechnology companies
    • 9.4.2. Academic Institutes
    • 9.4.3. Others

Chapter 10. Global Drug Discovery Outsourcing Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Drug Discovery Outsourcing Market, Regional Market Snapshot
  • 10.4. North America Drug Discovery Outsourcing Market
    • 10.4.1. U.S. Drug Discovery Outsourcing Market
      • 10.4.1.1. Workflow breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Therapeutics Area breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Drug Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Service Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.5. End user breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Drug Discovery Outsourcing Market
  • 10.5. Europe Drug Discovery Outsourcing Market Snapshot
    • 10.5.1. U.K. Drug Discovery Outsourcing Market
    • 10.5.2. Germany Drug Discovery Outsourcing Market
    • 10.5.3. France Drug Discovery Outsourcing Market
    • 10.5.4. Spain Drug Discovery Outsourcing Market
    • 10.5.5. Italy Drug Discovery Outsourcing Market
    • 10.5.6. Rest of Europe Drug Discovery Outsourcing Market
  • 10.6. Asia-Pacific Drug Discovery Outsourcing Market Snapshot
    • 10.6.1. China Drug Discovery Outsourcing Market
    • 10.6.2. India Drug Discovery Outsourcing Market
    • 10.6.3. Japan Drug Discovery Outsourcing Market
    • 10.6.4. Australia Drug Discovery Outsourcing Market
    • 10.6.5. South Korea Drug Discovery Outsourcing Market
    • 10.6.6. Rest of Asia Pacific Drug Discovery Outsourcing Market
  • 10.7. Latin America Drug Discovery Outsourcing Market Snapshot
    • 10.7.1. Brazil Drug Discovery Outsourcing Market
    • 10.7.2. Mexico Drug Discovery Outsourcing Market
  • 10.8. Middle East & Africa Drug Discovery Outsourcing Market
    • 10.8.1. Saudi Arabia Drug Discovery Outsourcing Market
    • 10.8.2. South Africa Drug Discovery Outsourcing Market
    • 10.8.3. Rest of Middle East & Africa Drug Discovery Outsourcing Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Albany Molecular Research Inc
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. EVOTEC
    • 11.3.3. Laboratory Corporation of America Holdings
    • 11.3.4. GenScript
    • 11.3.5. Pharmaceutical Product Development, LLC
    • 11.3.6. Charles River
    • 11.3.7. WuXi AppTec
    • 11.3.8. Merck & Co., Inc.
    • 11.3.9. Thermo Fisher Scientific Inc.
    • 11.3.10. Dalton Pharma Services

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption